188 related articles for article (PubMed ID: 28160485)
21. Pediatric Dilated Cardiomyopathy Patients Do Not Meet Traditional Cardiac Resynchronization Criteria.
Schiller O; Dham N; Greene EA; Heath DM; Alexander ME; Berul CI
J Cardiovasc Electrophysiol; 2015 Aug; 26(8):885-889. PubMed ID: 25884372
[TBL] [Abstract][Full Text] [Related]
22. Relation of QRS Duration to Clinical Benefit of Cardiac Resynchronization Therapy in Mild Heart Failure Patients Without Left Bundle Branch Block: The Multicenter Automatic Defibrillator Implantation Trial with Cardiac Resynchronization Therapy Substudy.
Biton Y; Kutyifa V; Cygankiewicz I; Goldenberg I; Klein H; McNitt S; Polonsky B; Ruwald AC; Ruwald MH; Moss AJ; Zareba W
Circ Heart Fail; 2016 Feb; 9(2):e002667. PubMed ID: 26823498
[TBL] [Abstract][Full Text] [Related]
23. Utility of cardiac magnetic resonance imaging, echocardiography and electrocardiography for the prediction of clinical response and long-term survival following cardiac resynchronisation therapy.
Ellims AH; Pfluger H; Elsik M; Butler MJ; Hare JL; Taylor AJ
Int J Cardiovasc Imaging; 2013 Aug; 29(6):1303-11. PubMed ID: 23568562
[TBL] [Abstract][Full Text] [Related]
24. QRS frequency characteristics help predict response to cardiac resynchronization in left bundle branch block less than 150 milliseconds.
Niebauer MJ; Rickard J; Polakof L; Tchou PJ; Varma N
Heart Rhythm; 2014 Dec; 11(12):2183-9. PubMed ID: 25068573
[TBL] [Abstract][Full Text] [Related]
25. Early Changes in QRS Frequency Following Cardiac Resynchronization Predict Hemodynamic Response in Left Bundle Branch Block Patients.
Niebauer MJ; Rickard J; Tchou PJ; Varma N
J Cardiovasc Electrophysiol; 2016 May; 27(5):594-9. PubMed ID: 26824741
[TBL] [Abstract][Full Text] [Related]
26. Impact of myocardial viability and left ventricular lead location on clinical outcome in cardiac resynchronization therapy recipients with ischemic cardiomyopathy.
Bose A; Kandala J; Upadhyay GA; Riedl L; Ahmado I; Padmanabhan R; Gewirtz H; Mulligan LJ; Singh JP
J Cardiovasc Electrophysiol; 2014 May; 25(5):507-513. PubMed ID: 24350650
[TBL] [Abstract][Full Text] [Related]
27. Profound differences in prognostic impact of left ventricular reverse remodeling after cardiac resynchronization therapy relate to heart failure etiology.
Martens P; Nijst P; Verbrugge FH; Dupont M; Tang WHW; Mullens W
Heart Rhythm; 2018 Jan; 15(1):130-136. PubMed ID: 28843420
[TBL] [Abstract][Full Text] [Related]
28. Three-dimensional interlead distance predicts response and outcomes after cardiac resynchronization therapy.
Clementy N; Laborie G; Pierre B; Benhenda N; Babuty D; Fauchier L
Arch Cardiovasc Dis; 2017 Nov; 110(11):590-598. PubMed ID: 28734687
[TBL] [Abstract][Full Text] [Related]
29. Patient-assessed short-term positive response to cardiac resynchronization therapy is an independent predictor of long-term mortality.
Reitan C; Bakos Z; Platonov PG; Höijer CJ; Brandt J; Wang L; Borgquist R
Europace; 2014 Nov; 16(11):1603-9. PubMed ID: 24681763
[TBL] [Abstract][Full Text] [Related]
30. New York Heart Association functional class, QRS duration, and survival in heart failure with reduced ejection fraction: implications for cardiac resychronization therapy.
Braunschweig F; Linde C; Benson L; Ståhlberg M; Dahlström U; Lund LH
Eur J Heart Fail; 2017 Mar; 19(3):366-376. PubMed ID: 27338764
[TBL] [Abstract][Full Text] [Related]
31. Additive Prognostic Value of Echocardiographic Global Longitudinal and Global Circumferential Strain to Electrocardiographic Criteria in Patients With Heart Failure Undergoing Cardiac Resynchronization Therapy.
Delgado-Montero A; Tayal B; Goda A; Ryo K; Marek JJ; Sugahara M; Qi Z; Althouse AD; Saba S; Schwartzman D; Gorcsan J
Circ Cardiovasc Imaging; 2016 Jun; 9(6):. PubMed ID: 27252359
[TBL] [Abstract][Full Text] [Related]
32. Absolute survival after cardiac resynchronization therapy according to baseline QRS duration: a multinational 10-year experience: data from the Multicenter International CRT Study.
Gasparini M; Leclercq C; Yu CM; Auricchio A; Steinberg JS; Lamp B; Klersy C; Leyva F
Am Heart J; 2014 Feb; 167(2):203-209.e1. PubMed ID: 24439981
[TBL] [Abstract][Full Text] [Related]
33. A new score system for predicting response to cardiac resynchronization therapy.
Kang Y; Cheng L; Cui J; Li L; Qin S; Su Y; Mao J; Gong X; Chen H; Pan C; Shen X; He B; Shu X
Cardiol J; 2015; 22(2):179-87. PubMed ID: 25428735
[TBL] [Abstract][Full Text] [Related]
34. Electrocardiographic parameters predict super-response in cardiac resynchronization therapy.
Cvijić M; Žižek D; Antolič B; Zupan I
J Electrocardiol; 2015; 48(4):593-600. PubMed ID: 25968915
[TBL] [Abstract][Full Text] [Related]
35. Effects of cardiac resynchronization therapy on disease progression in patients with congestive heart failure.
Bonanno C; Ometto R; Pasinato S; Finocchi G; La Vecchia L; Fontanelli A
Ital Heart J; 2004 May; 5(5):364-70. PubMed ID: 15185900
[TBL] [Abstract][Full Text] [Related]
36. Adding the implantable cardioverter-defibrillator to cardiac resynchronization therapy is associated with improved long-term survival in ischaemic, but not in non-ischaemic cardiomyopathy.
Witt CT; Kronborg MB; Nohr EA; Mortensen PT; Gerdes C; Jensen HK; Nielsen JC
Europace; 2016 Mar; 18(3):413-9. PubMed ID: 26378089
[TBL] [Abstract][Full Text] [Related]
37. Implantation feasibility, procedure-related adverse events and lead performance during 1-year follow-up in patients undergoing triple-site cardiac resynchronization therapy: a substudy of TRUST CRT randomized trial.
Lenarczyk R; Kowalski O; Sredniawa B; Pruszkowska-Skrzep P; Mazurek M; Jędrzejczyk-Patej E; Woźniak A; Pluta S; Głowacki J; Kalarus Z
J Cardiovasc Electrophysiol; 2012 Nov; 23(11):1228-36. PubMed ID: 22651239
[TBL] [Abstract][Full Text] [Related]
38. Right ventricular function assessed by cardiac magnetic resonance predicts the response to resynchronization therapy.
Manca P; Cossa S; Matta G; Scalone A; Tola G; Schintu B; Setzu A; Melis M; Giardina A; Corda M; Sinagra G; Porcu M
J Cardiovasc Med (Hagerstown); 2020 Apr; 21(4):299-304. PubMed ID: 32108126
[TBL] [Abstract][Full Text] [Related]
39. Delayed intrinsicoid deflection onset in surface ECG lateral leads predicts left ventricular reverse remodeling after cardiac resynchronization therapy.
Del-Carpio Munoz F; Powell BD; Cha YM; Wiste HJ; Redfield MM; Friedman PA; Asirvatham SJ
Heart Rhythm; 2013 Jul; 10(7):979-87. PubMed ID: 23542361
[TBL] [Abstract][Full Text] [Related]
40. Non-invasively quantified changes in left ventricular activation predict outcomes in patients undergoing cardiac resynchronization therapy.
Friedman DJ; Emerek K; Hansen SM; Polcwiartek C; Sørensen PL; Loring Z; Sutter J; Søgaard P; Kisslo J; Graff C; Atwater BD
J Cardiovasc Electrophysiol; 2019 Nov; 30(11):2475-2483. PubMed ID: 31535746
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
